Randomized controlled clinical study to evaluate the efficacy of Rajrajeshwar Ras orally and Siddharthak Tailam topically in the management of Kitibh Kushtha with special refrance to Psoriasis in age group from 18-70 years.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- In present clinical trial, the patients was
研究概览
简要总结
Kitibha Kushtha is one of the Kshudra Kushtha. Here Tridosha, Rasa, Rakta, Mamsa, Ambu are affected. Rakta Dusti is the main cause of Twak Vikaras.kushtha is one among the Ashtamahagada. There is the involvement of Tridosha in all Kushtha but the predominance of Dosha makes the types & manifestations of Kushtha different.Among different types of Kushtha Kitibha Kushtha is described as one with symptoms like Kinakhara sparsha (Scaling), Ugrakandu (Severe pruritis), Parusha (Dryness), Srava (Dischange), Vritta (Oval to round Lesions), Ghana (Elevation), Shyawan (Greyish Discolouration), Snigdha Krushna (Erythematous Plaques). Kitibha Kushtha is predominantly caused by vitiated Kapha and Vata.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Age group above 18 and below 70 years. 2) Patient having classical signs and symptoms of kitibh kushtha Symptoms:.
- •A) Kinakhara sparsha (Scaling), B) Ugrakandu (Severe pruritis) C) Parusha (Dryness), D) Srava (Dischange), E) Vritta (Oval to round Lesions), F) Ghana (Elevation), G) Shyawan (Greyish Discolouration), H) Snigdha Krushna (Erythematous Plaques) 3) Patient willing for clinical trial. Irrespective of gender, occupation, Religion, economical Barrier. 4) Patient who will fulfil criteria and take regular medicines with regular follow up.
排除标准
- •Age group below 18 years and above 70 years.
- •Pregnant and lactating mother.
- •Infective origins like a) Koch ‘s disease b) Hansen ‘s disease c) Scabies d) Eczema e) Fungal infection /herpes zoster.
- •Immune compromised like HIV 5) Diabetic wound 6) Malignancies 7) Renal diseases like CKD.
结局指标
主要结局
In present clinical trial, the patients was
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
diagnosed on the basis of signs and symptoms
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
describe in ayurvedic text i. e subjective criteria
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
A) Kinakhara sparsha (Scaling),
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
B) Ugrakandu (Severe pruritis)
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
C) Parusha (Dryness),
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
D) Srava (Dischange),
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
E) Vritta (Oval to round Lesions),
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
F) Ghana (Elevation),
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
G) Shyawan (Greyish Discolouration),
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
H) Snigdha Krushna (Erythematous Plaques)
时间窗: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)
次要结局
- 1)PASI Scale (Psoriasis Area And Severity Index)(2)DLQI Scale (Dermatology Life Quality Index))
研究者
Dr Supriya Bhaskarrao Kadam
Dayabhai maoji majithiya Ayurved mahavidyalaya Yavatmal, Maharashtra